Who invested in Kite Pharma?
Kite Pharma's investors include Alta Partners, Riverbank Capital Securities and Arie Belldegrun.
United States · Venture startup
5 rounds we have observed, with the 3 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$86Mraised across 5 rounds since 2011, from 5 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
From a historical funding recordSEC filing: $50M sold, first sale Apr 2014
Reported by fiercebiotech.comSEC filing: $16M sold, first sale May 2013
No investor was named in the report.
From a historical funding recordSEC filing: $250K sold, first sale Nov 2012
No investor was named in the report.
Reported by sec.govSEC filing: $250K sold, first sale Nov 2012
Reported by finance.yahoo.comSEC filing: $12M sold, first sale Feb 2011
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Kite Pharma's investors include Alta Partners, Riverbank Capital Securities and Arie Belldegrun.
Kite Pharma has raised $86M across 5 rounds since 2011.
Kite Pharma's most recent round was a Venture of $50M in Apr 2014.
Its most recent round, $50M in Apr 2014, is also its largest on record.
Kite Pharma's first round on record, in Mar 2011, was backed by Riverbank Capital Securities.
Kite Pharma's latest named round is a Venture, in Apr 2014.
Kite Pharma is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.